Annual report pursuant to Section 13 and 15(d)

COMMON STOCK OPTIONS AND WARRANTS

v3.24.1
COMMON STOCK OPTIONS AND WARRANTS
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
COMMON STOCK OPTIONS AND WARRANTS

NOTE 13 – COMMON STOCK OPTIONS AND WARRANTS

 

Options

 

2023

 

During the second quarter of 2023, the Company’s Board of Directors granted 293,117 new stock options and in the fourth quarter granted a further 170,000 new stock options both with a strike price of $4.22 per share to 19 key employees and one contract employee. These options were awarded as a one-time award as a retention incentive and have a fair value of approximately $556,000 for the April 1, 2023 awards and approximately $172,000 for the December 1, 2023 award and carry a three-year vesting period. The issuance of these options generated stock option compensation expense in the year in the amount of $269,611 and a balance of unamortized stock option compensation expense of $458,389, that is being expensed over the following 2.0 years.

 

During the first quarter of 2023, two former staff members forfeited 1,608 non-qualified stock options as the options expired.

 

2022

 

During the first quarter of 2022, the Company’s Board of Directors granted 665,000 new stock options and in the third quarter granted a further 20,000 new stock options both with a strike price of $6.41 per share to 16 key employees. These options were awarded as a one-time award as a retention incentive and have a fair value of $1,596,804 for the January 1, 2022 awards and $33,096 for the July 1, 2022 award and carry a three-year vesting period. The issuance of these options generated stock option compensation expense in the year in the amount of $819,191 and a balance of unamortized stock option compensation expense of $458,389, that is being expensed over the following 2.0 years.

 

During the second quarter of 2022, three former staff members forfeited 110,000 non-qualified stock options. Additionally, during the third quarter of 2022, two employees forfeited 80,000 non-qualified stock options.

 

During the third quarter of 2021, the shareholders approved the issuance of up to one million shares or share equivalents in the form of stock options for the purposes of share issuance for compensation to Board Members and grants to certain staff members for recruiting and retention. On August 5, 2021, the Company filed an S-8 registration statement in concert with the 2021 Equity Incentive Plan. The plan covers a period of ten years.

                         
                Weighted        
          Weighted     Average        
          Average     Remaining     Aggregate  
          Exercise     Contractual     Intrinsic  
    Shares     Price     Term (Years)     Value  
Outstanding at December 31, 2021     431,266     $ 4.98       3.4      $ 197,506  
Granted     685,000     $ 6.41       4.0        
Forfeited     (190,000 )   $ 6.41              
Outstanding at December 31, 2022     926,266     $ 5.74       3.3        
Exercisable at December 31, 2022     404,599     $ 5.02       3.3        
                                 
Outstanding at December 31, 2022     926,266     $ 5.74       3.3        
Granted     463,117     $ 4.22       4.35        
Exercised/Forfeited     (1,608 )   $ 14.00              
Outstanding at December 31, 2023     1,387,775     $ 5.23       3.0     $  
Exercisable at December 31, 2023     581,324     $ 5.38       1.8        

 

The fair value of the incentive stock option grants for the years ended December 31, 2023 and 2022 were estimated using the following weighted- average assumptions:

           
    For the Years Ended
December 31,
 
    2023     2022  
Risk free interest rate 3.73%       0.97%3.15%  
Expected term in years     3.50       3.253.50  
Dividend yield            
Volatility of common stock     54%118%       72% 80%  
Weighted average grant date fair value per option     $1.57       $2.33   

 

Warrants

 

2023

 

During the first and fourth quarters of 2023, warrants held by 48 holders representing 102,947 shares expired. All of the expired warrants can no longer be exercised.

 

2022

 

During the fourth quarter of 2022, warrants held by 63 holders representing 1,228,875 shares expired. All of the expired warrants can no longer be exercised.

 

                       
                Weighted        
          Weighted     Average        
          Average     Remaining     Aggregate  
    Number of     Exercise     Contractual     Intrinsic  
    Warrants     Price     Term (Years)     Value  
Outstanding at December 31, 2021     1,376,466     $ 8.18       1.9        
Warrants expired, forfeited, cancelled or exercised     (1,228,875 )                
Warrants issued         $              
Outstanding at December 31, 2022     80,091     $ 8.63       0.98        
Exercisable at December 31, 2022     80,091     $ 8.63       0.8        
                                 
Outstanding at December 31, 2022     80,091     $ 8.63       0.8        
Warrants expired, forfeited, cancelled or exercised     (102,947 )   $              
Warrants issued         $              
Outstanding at December 31, 2023     44,644     $ 7.70       0.7        
Exercisable at December 31, 2023     44,644     $ 7.70       0.7